Associate Director of Regulatory Affairs - Cell Therapy

Immix Biopharma (Nasdaq: IMMX)

Toronto

On-site

CAD 150,000 - 210,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Immix Biopharma, Inc. in Canada is seeking an Associate Director of Regulatory Affairs to lead regulatory strategy and execution for cell therapy programs.

You will prepare, submit, and maintain regulatory documents to meet FDA/EMA/Health Canada/MHRA requirements for investigational products, ensuring compliance and timelines. The role requires strong attention to detail, excellent communication, and experience with regulatory submissions, eCTD familiarity, and cross-functional collaboration

Qualifications

  • Bachelor’s degree in life sciences, pharmacy, or related field required; advanced degree preferred.
  • 3–5 years of experience in regulatory affairs within biopharma.
  • Familiarity with FDA/EMA/Health Canada/MHRA regulations and regulatory submission requirements.
  • Strong written and verbal communication; excellent organizational and project management abilities.

Responsibilities

  • Assist in preparation, review, and submission of INDs, amendments, and other regulatory filings.
  • Monitor regulatory changes and communicate updates to relevant teams.
  • Coordinate with internal departments and external partners to gather documentation for submissions.
  • Maintain accurate records of regulatory correspondence and submissions.
  • Support audits and inspections by regulatory authorities.

Skills

Regulatory affairs experience
FDA/EMA knowledge
Regulatory documentation
Attention to detail
Communication skills

Education

Bachelor’s degree in life sciences, pharmacy, or related field
Advanced degree preferred

Tools

eCTD submissions
Regulatory software tools

Job description

Associate Director of Regulatory Affairs - Cell Therapy
Our 3 Core Values
  • Integrity
  • Initiative
What You’ll Do

The Associate Director of Regulatory Affairs will support the regulatory strategy and execution for clinical trials conducted under FDA/EMA/Other Regulatory agencies regulations. This role is responsible for preparing, submitting, and maintaining regulatory documents and ensuring compliance with all applicable laws and guidelines. The ideal candidate will demonstrate strong attention to detail, analytical skills, and knowledge of FDA/EMA/HealthCanada/MHRA requirements for investigational products.

Key Responsibilities
  • Assist in the preparation, review, and submission of INDs, amendments, and other regulatory filings.
  • Monitor regulatory changes and communicate updates to relevant teams to ensure ongoing compliance.
  • Coordinate with internal departments and external partners to gather necessary documentation for regulatory submissions.
  • Maintain accurate records of regulatory correspondence and submissions.
  • Support audits and inspections by regulatory authorities.
Qualifications
  • Bachelor’s degree in life sciences, pharmacy, or a related field; advanced degree preferred.
  • 3-5 years of experience in regulatory affairs within the biopharmaceutical industry.
  • Familiarity with FDA/EMA/HealthCanada/MHRA regulations, clinical trial processes, and regulatory submission requirements.
  • Strong written and verbal communication skills.
  • Excellent organizational and project management abilities.
Preferred Skills
  • Familiarity with eCTD submissions and regulatory software tools.
  • Ability to work effectively in a collaborative, fast-paced environment.
  • Attention to detail and analytical problem-solving skills.
About Immix Biopharma, Inc.

Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a global leader in AL Amyloidosis. AL Amyloidosis is a devastating disease where the immune system, that’s supposed to protect, instead produces toxic light chains, clogging up the heart, kidney and liver, causing organ failure and death. Our lead candidate is sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy NXC-201 with a proprietary CD3ζ, CD8 hinge and binder “digital filter” designed to filter out non‑specific activation. NXC‑201 teaches the immune system to recognize and eliminate the source of the toxic light chains. NXC‑201 is being evaluated in the U.S. multi‑center study for relapsed/refractory AL Amyloidosis NEXICART‑2 (NCT06097832), with a potentially registrational design. NXC‑201 has been awarded Breakthrough Therapy Designation (BTD) and Regenerative Medicine Advanced Therapy (RMAT) by the US FDA and Orphan Drug Designation (ODD) by FDA and in the EU by the EMA.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Clinical Research Associate II (Cell Therapy)
Clinical Research Associate II (Cell Therapy)

Immix Biopharma (Nasdaq: IMMX) • Toronto, Hamilton

On-site
CAD 70,000 - 90,000
Regulatory Affairs Director, Cell Therapy & IND Submissions
Regulatory Affairs Director, Cell Therapy & IND Submissions

Immix Biopharma (Nasdaq: IMMX) • Toronto

On-site
CAD 150,000 - 210,000
External QA Specialist/Manager
External QA Specialist/Manager

Peptide Atlas • Vancouver

On-site
CAD 84,000 - 122,000
Equity
Annual bonus
RRSP contribution
+2
VP, Late-Stage & Commercial Biologics Development
VP, Late-Stage & Commercial Biologics Development

AbCellera • Vancouver

On-site
CAD 250,000 - 380,000
Equity
Annual bonus
RRSP contribution
+1
QC Analyst II
QC Analyst II

Peptide Atlas • Vancouver

On-site
CAD 76,000 - 95,000
Equity participation
Annual bonus
RRSP contribution
+3
Director, Combination Products & Device Development
Director, Combination Products & Device Development

AbCellera Biologics Inc. • Vancouver

On-site
CAD 200,000 - 250,000
Equity
Annual bonus
RRSP contribution 6%
+3
Director, CMC Quality
Director, CMC Quality

Peptide Atlas • Vancouver

On-site
CAD 180,000 - 220,000
Equity
Annual bonus
RRSP contribution
+4
QA Specialist - Batch Record Review
QA Specialist - Batch Record Review

AbCellera Biologics Inc. • Vancouver

On-site
CAD 82,000 - 102,000
Equity
Annual bonus
RRSP contribution
+1
Project Manager, CMC & Product Development
Project Manager, CMC & Product Development

Morphocell Technologies Inc. • Laval

Hybrid
CAD 90,000 - 120,000
Medical, vision, dental insurance
RRSP matching
Competitive compensation
Senior QC Data Reviewer
Senior QC Data Reviewer

Peptide Atlas • Vancouver

On-site
CAD 88,000 - 110,000
Equity
Annual bonus
RRSP contribution
+2